Faster global financial news!
Vaccine
-
BioNTech shares fell 1.2% in premarket trading after BMO downgraded the stock and cut its price target from $128 to $105, citing declining vaccine demand and the termination of a cancer vaccine trial.
BioNTech shares fell 1.2% in premarket trading after BMO downgraded the stock and cut its price target from $128 to $105, citing declining vaccine demand and the termination of a cancer vaccine trial.
-
Moderna Reports Second-Quarter Financial Results, with Revenue Exceeding Expectations and Profits for the Sixth Consecutive Quarter
Biotechnology company Moderna released its second-quarter 2026 financial results on July 31, reporting revenue of $389 million, exceeding the market’s consensus estimate of $236.36 million. This marks
-
BioNTech shares fell 1.2% in premarket trading after BMO downgraded the stock and cut its price target from $128 to $105, citing declining vaccine demand and the termination of a cancer vaccine trial.
BioNTech shares fell 1.2% in premarket trading after BMO downgraded the stock and cut its price target from $128 to $105, citing declining vaccine demand and the termination of a cancer vaccine trial.
-
Moderna Reports Second-Quarter Financial Results, with Revenue Exceeding Expectations and Profits for the Sixth Consecutive Quarter
Biotechnology company Moderna released its second-quarter 2026 financial results on July 31, reporting revenue of $389 million, exceeding the market’s consensus estimate of $236.36 million. This marks
- No data
Vaccine
24H Trending
-
1
NOBI Token Value Analysis: Platform Transformation and Token Status
-
2
Databricks Chief Revenue Officer Ron Gabrisko stated that the company's annual recurring revenue (ARR) has grown from less than $1 million to over $7 billion, with approximately $1.7 billion of that coming from AI-related revenue.
-
3
IEA Says Ukraine Strikes Degrade Russian Oil-Refining Industry, With Sanctions Preventing Recovery from Drone Attacks
-
4
Bridgewater Associates Co-CIO Greg Jensen Compares Current AI Moment to February 2020
-
5
Anthropic Warns AI Could Be Used for Bioweapons, Has Blocked Several Related Attempts
-
6
Indonesian Builder PT PP to Restructure $1 Billion Bank Loans
-
7
a16z Partner: AI is pushing the "power law distribution" of tech investments to the extreme, traditional SaaS faces the risk of being abandoned by the era.
-
8
Neko Health CEO Hjalmar Nilsonne predicts AI and personalized medicine could help people live longer
-
9
AMB Coin: Founder, Project Evolution, and Current Price Analysis
-
10
Meta FPS (MFPS) Token Status: Trading Market and Project Background Analysis
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
